FDA Backtracks Over GLP-1s' Effects on Pancreas
The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a link between GLP-1 drugs used to treat type 2 diabetes and pancreatic maladies, including acute pancreatitis and pancreatic cancer.
GLP-1 drugs, which work by stimulating the body to produce insulin, include Bristol-Myers Squibb's Byetta and Bydureon, Merck's Januvia and Janumet, and Novo Nordisk's Victoza.
Full Article
<-- Exercising during pregnancy reduces excessive weight gain and the possibility of suffering from associated illnesses
Meat and cheese may be as bad for you as smoking -->